Zevtera / Mabelio (ceftobiprole)

Indicaton

Hospital- and community-acquired pneumonia

Therapeutic indications

Infectious disease

Type of product

Small molecule

Table

Phase

Marketed
Partnering status

Partnered
Partner

Advanz for Europe (excl. Nordics) and Israel; Unimedic for Nordics; Hikma for MENA region, Knight Grupo Biotoscana for Latin America; Avir for Canada, CR Gosun for China, JSC Lancet for Eurasian Economic Union
Available in

Major European and several international markets

You may also be interested in

Cadazolid

Crohn's disease

Phase II started

Cresemba (isavuconazole)

Invasive aspergillosis and mucormycosis

Zevtera / Mabelio (ceftobiprole)

Acute bacterial skin and skin structure infections (ABSSSI)

Phase III completed